Videolaryngoscopy Compared to Direct Laryngoscopy (LARA)

January 3, 2024 updated by: Marc Kriege, MD, Johannes Gutenberg University Mainz

Evaluation of Videolaryngoscopy (McGrath Mac) Compared to Direct Laryngoscopy for Rapid Sequence Intubation in Operating Room

Videolaryngoscope (Macintosh-type blade) compared with direct laryngoscopy for rapid sequence intubation in the operating room

Study Overview

Detailed Description

Video laryngoscopy (VL) is a etablished method of achieving tracheal intubation and there is evidence to show that visualisation of larynx can be improved using VL in failed tracheal Intubation (NAP 4 Report). VL has been shown to improve first attempt success compared to direct laryngoscopy in many clinical settings including intensive care unit (ICU) and emergency department (ED). This is a proposed comparison study of a VL, use in patients with a high risk for pulmonary Aspiration and requiring tracheal Intubation. An national, multi-center, prospective randomized comparative trial is proposed testing the superiority of oral tracheal intubation with the McGrath® MAC versus conventional laryngoscope in adult patients under general anesthesia.

Study Type

Interventional

Enrollment (Actual)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Rhineland-Palatinate
      • Mainz, Rhineland-Palatinate, Germany, D55131
        • Department of Anesthesiology,Prof. C. Werner, Universitätsmedizin of the JG University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Age ≥ 18 Years
  • capacity to consent
  • Present written informed consent of the research participant

Exclusion Criteria:

  • Age <18 years
  • Existing pregnancy
  • Lack of consent
  • inability to consent
  • Difficult Airway / Defined Indications for awake intubation
  • Participation in another study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: McGrath MAC
First pass success rate using the McGrath Mac
in a randomized order we evaluate the first pass success rate of the tracheal tube into the trachea.
Experimental: Macintosh Laryngoscope
First pass success rate using the Macintosh laryngoscope
in a randomized order we evaluate the first pass success rate of the tracheal tube into the trachea.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
First pass Intubation success rate
Time Frame: at intubation in 60 seconds
successful tracheal intubation at the first attempt, compared to more than one attempt
at intubation in 60 seconds

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Time to ventilation
Time Frame: at intubation in 120 seconds
From Insertion of the blase into the mouth until first ventilation
at intubation in 120 seconds
Cormack and Lehane Classification
Time Frame: < 120 seconds
after insert the device the user describe the glottis visualisation
< 120 seconds
Overall success rate
Time Frame: < 120 seconds
after two attempts using defined rescue techniques (e.g. rigid stylet, laryngeal mask)
< 120 seconds
Intubation difficult score
Time Frame: < 120 seconds
Based on parameters known to be associated with difficult intubation (0=easy intubation to 5=difficult intubation
< 120 seconds
adverse events
Time Frame: after 24 hours
sore throat
after 24 hours
complications
Time Frame: < 120 seconds
mucosal injury
< 120 seconds

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Marc Kriege, MD, PhD, University JG, Mainz

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 24, 2021

Primary Completion (Actual)

July 1, 2023

Study Completion (Actual)

August 31, 2023

Study Registration Dates

First Submitted

March 9, 2021

First Submitted That Met QC Criteria

March 9, 2021

First Posted (Actual)

March 12, 2021

Study Record Updates

Last Update Posted (Actual)

January 5, 2024

Last Update Submitted That Met QC Criteria

January 3, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pulmonary Aspiration of Gastric Contents

Clinical Trials on McGrath Mac

3
Subscribe